He has been awarded a DKFZ International Graduate School fellowship to fund his PhD studies within the lab. Ian will join the group from Italy in the summer of 2021 and will study the effect of interferon therapy on dormant malignant stem cells in the setting of JAK2-mutated myeloproliferative neoplasms.